Children vaccine debate headed to Colorado House committee

A proposal to make it harder to send kids to school without their vaccines cleared its first hurdle Thursday in a Colorado House committee. The proposal has powerful bipartisan backers, but it sparked intense opposition from some. Colorado is one of 18 states that allow parents and students to opt out of getting required vaccines if they submit a statement of exemption based on religious or personal beliefs. The bill would require parents of students seeking a personal exemption to watch a video that discusses the benefits and risks of immunization to the student. Religious and medical exemptions would not be affected. The House Health, Insurance & Environment Committee approved the bill 9-2 after hours of emotional testimony. Sponsors said the change is needed because of whooping-coug...

Study linking vaccine to autism “elaborate fraud,” journal says

The first study to link a childhood vaccine to autism was based on doctored information about the children involved, according to a new report on the widely discredited research. The conclusions of the 1998 paper by Andrew Wakefield and colleagues was renounced by 10 of its 13 authors and later retracted by the medical journal Lancet, where it was published. Still, the suggestion the MMR (measles-mumps-rubella) shot was connected to autism spooked parents worldwide, and immunization rates for measles, mumps and rubella have never fully recovered. A new examination found, by comparing the reported diagnoses in the paper to hospital records, that Wakefield and colleagues altered facts about patients in their study. The analysis, by

Vaccine against breast cancer in the works

A team at the Cleveland Clinic has laid the scientific groundwork for a breast-cancer vaccine that may work much the same way as immunizations for mumps and measles. The vaccine is made using a protein called alpha-lactalbumin, which is prevalent in a wide range of breast cancers, scientists said last week. “This is a first-of-its-kind prototype,” said Dr. Vincent Tuohy, principal investigator of the research. While the vaccine so far has been tested only in mice, Tuohy said human clinical trials could begin as early as next year, though a marketable vaccine is at least a decade away. He also predicted that the vaccine one day could be administered routinely to women starting at age 40. Dr. Janice Lu, a specialist in breast cancer and director of medical oncology at Stony Brook...